Efficacy of a skin barrier repair cream (Dermalex Eczema) in atopic dermatitis patients - Efficacy of Dermalex eczema in atopic dermatitis patients

Academisch Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•Clinically diagnosed atopic dermatitis;- Mild to moderate atopic dermatitis, according to total SCORAD score (score <25) ;- Age between 18 and 70 years;- Written informed consent ;- At least two symmetrical (i.e. left and right side of the body) skin sites with comparable AD severity (Measured in SCORAD-score)

•Extensive UV exposure in the last 14 days before study and/or expected during the study. ;- Other skin disease other than AD.;- Use of antibiotics prior to (4 weeks) the study and/or expected use during the study.;- Use of systemic suppressing drugs (e.g. prednisone, methothrexate) prior to (4 weeks) the study and/or expected use during the study;-Severe disorders within the last 6 months before study (e.g. cancer, acute cardiac or circularity disorders, HIV, infectious hepatitis);- Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements.

发起方